Problems with Gabapentin Misuse are a Sign of Improper Prescribing: Report
A new report warns that off-label prescribing is a driving factor behind increasing gabapentin misuse and overdoses.
A new report warns that off-label prescribing is a driving factor behind increasing gabapentin misuse and overdoses.
A new FDA warning links nerve pain drugs like Neurontin and Lyrica to an increased risk of breathing problems when used with opioids or given to patients with pre-existing respiratory…